Your browser doesn't support javascript.
loading
Design and rationale of a prospective, randomized, non-inferiority trial to determine the safety and efficacy of the Biolimus A9™ drug coated balloon for the treatment of in-stent restenosis: First-in-man trial (REFORM).
Traynor, Bryan P; Fitzgerald, Sean; Alfonso, Fernando; O'Kane, Peter; Sabaté, Manel; Tölg, Ralph; Trevelyan, Jasper; Hahn, Joo-Yong; Mylotte, Darren; Wöhrle, Jochen; Rai, Himanshu; Cortese, Bernardo; Morice, Marie-Claude; Schuette, Diane; Copt, Samuel; Oldroyd, Keith G; Byrne, Robert A.
Afiliação
  • Traynor BP; Cardiovascular Research Institute (CVRI) Dublin, Mater Private Network, Dublin, Ireland; School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
  • Fitzgerald S; Cardiovascular Research Institute (CVRI) Dublin, Mater Private Network, Dublin, Ireland; School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
  • Alfonso F; Cardiology Department, Hospital Universitario de la Princesa, IIS-IP, CIBER-CV, Madrid, Spain.
  • O'Kane P; Royal Bournemouth Hospital, UK.
  • Sabaté M; Barcelona Hospital Clinic, Cardiology, Barcelona, Spain.
  • Tölg R; Heart Centre, Segeberger Kliniken, Bad Segeberg, Germany.
  • Trevelyan J; Worcestershire Acute Hospitals NHS Trust, Worcester, UK.
  • Hahn JY; Division of Cardiology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Mylotte D; Galway University Hospital, SAOLTA Health Care Group, and National University of Ireland, Galway, Ireland.
  • Wöhrle J; Department of Cardiology and Intensive Care, Medical Campus Lake Constance, Friedrichshafen, Germany.
  • Rai H; Cardiovascular Research Institute (CVRI) Dublin, Mater Private Network, Dublin, Ireland; School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
  • Cortese B; Interventional Cardiology, Fondazione Ricerca e Innovazione Cardiovascolare, Milan, Italy.
  • Morice MC; Cardiovascular European Research Center, Paris, France.
  • Schuette D; Biosensors International, Singapore.
  • Copt S; Biosensors International, Singapore.
  • Oldroyd KG; Biosensors International, Singapore.
  • Byrne RA; Cardiovascular Research Institute (CVRI) Dublin, Mater Private Network, Dublin, Ireland; School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland. Electronic address: robert.byrne@materprivate.ie.
Cardiovasc Revasc Med ; 56: 75-81, 2023 11.
Article em En | MEDLINE | ID: mdl-37328392
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fármacos Cardiovasculares / Reestenose Coronária / Stents Farmacológicos Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fármacos Cardiovasculares / Reestenose Coronária / Stents Farmacológicos Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article